Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
Molecular Systems Biology|December 31, 2019
A solid-phase transfection platform for arrayed CRISPR screensÖzdemirhan Serçin, Sabine Reither, Paris Roidos, et al.
Cancers|December 23, 2020
Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation StudiesMaria Joana Catarata, Rui Medeiros, Maria José Oliveira, et al.
Lung Cancer (Amsterdam, Netherlands)|December 30, 2015
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC)Juliane Rieber, Alexander Deeg, Elena Ullrich, et al.
Genes, Chromosomes & Cancer|October 18, 2012
Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinomaHui Wu, Daniel Haag, Thomas Muley, et al.
Lung Cancer (Amsterdam, Netherlands)|February 2, 2021
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experienceFlorian Eichhorn, Laura V Klotz, Mark Kriegsmann, et al.
British Journal of Cancer|May 3, 2025
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLCDörte Nitschkowski, Tim Vierbuchen, Holger Heine, et al.
The Journal of Pathology|July 17, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cellsBenedikt Müller, Michael Bovet, Yi Yin, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissueSandra Gottschling, Anna Jauch, Ruprecht Kuner, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Translational Lung Cancer Research|December 15, 2022
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approachLaura V Klotz, Hans Hoffmann, Rajiv Shah, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Molecular Systems Biology|December 31, 2019
A solid-phase transfection platform for arrayed CRISPR screensÖzdemirhan Serçin, Sabine Reither, Paris Roidos, et al.
Cancers|December 23, 2020
Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation StudiesMaria Joana Catarata, Rui Medeiros, Maria José Oliveira, et al.
Lung Cancer (Amsterdam, Netherlands)|December 30, 2015
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC)Juliane Rieber, Alexander Deeg, Elena Ullrich, et al.
Genes, Chromosomes & Cancer|October 18, 2012
Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinomaHui Wu, Daniel Haag, Thomas Muley, et al.
Lung Cancer (Amsterdam, Netherlands)|February 2, 2021
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experienceFlorian Eichhorn, Laura V Klotz, Mark Kriegsmann, et al.
British Journal of Cancer|May 3, 2025
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLCDörte Nitschkowski, Tim Vierbuchen, Holger Heine, et al.
The Journal of Pathology|July 17, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cellsBenedikt Müller, Michael Bovet, Yi Yin, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissueSandra Gottschling, Anna Jauch, Ruprecht Kuner, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Translational Lung Cancer Research|December 15, 2022
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approachLaura V Klotz, Hans Hoffmann, Rajiv Shah, et al.
Pageof 23